ArticleCurrent microbiology2025
Seed Endophytic Bacteria from Manilkara zapota L. and Their Influence as Rice Seed Priming Agents.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Auxin-Rich Extract from Pseudomonas rhodesiae Enhances Cadmium Tolerance and Uptake in Cattail.Current microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, seed endophytes have gained significant attention due to their impact on the ecology, health, and productivity of host plants. Extensive research is being conducted to explore novel endophytic bacteria for sustainable crop improvement. Manilkara zapota L. P. Royen (Sapotaceae) is a highly stress-tolerant tree widely cultivated in tropical countries, yet its associated endophytes remain unexplored. In this study, nine bacterial isolates were obtained from M. zapota seeds, of which three (LA2, LA4, and NS1) were selected based on their IAA production capability which ranged from 2.3, 6.34, and 16.1 µg mL
Indexed as
Identifiers
40317325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.